nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—SRMS—brain—Creutzfeldt-Jakob disease	0.00164	0.00274	CbGeAlD
Bosutinib—CAMK1D—central nervous system—Creutzfeldt-Jakob disease	0.00163	0.00274	CbGeAlD
Bosutinib—STK4—cerebellum—Creutzfeldt-Jakob disease	0.00162	0.00271	CbGeAlD
Bosutinib—STK24—central nervous system—Creutzfeldt-Jakob disease	0.00162	0.00271	CbGeAlD
Bosutinib—MAP2K1—spinal cord—Creutzfeldt-Jakob disease	0.00161	0.00269	CbGeAlD
Bosutinib—FES—brain—Creutzfeldt-Jakob disease	0.0016	0.00269	CbGeAlD
Bosutinib—EPHA8—brain—Creutzfeldt-Jakob disease	0.0016	0.00269	CbGeAlD
Bosutinib—VRK2—brain—Creutzfeldt-Jakob disease	0.0016	0.00269	CbGeAlD
Bosutinib—CAMK1D—cerebellum—Creutzfeldt-Jakob disease	0.0016	0.00267	CbGeAlD
Bosutinib—CSK—spinal cord—Creutzfeldt-Jakob disease	0.00159	0.00267	CbGeAlD
Bosutinib—SIK1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00159	0.00267	CbGeAlD
Bosutinib—IRAK4—lymphoid tissue—Creutzfeldt-Jakob disease	0.00159	0.00267	CbGeAlD
Bosutinib—CSNK1A1—spinal cord—Creutzfeldt-Jakob disease	0.00158	0.00265	CbGeAlD
Bosutinib—STK24—cerebellum—Creutzfeldt-Jakob disease	0.00158	0.00264	CbGeAlD
Bosutinib—HCK—spinal cord—Creutzfeldt-Jakob disease	0.00157	0.00264	CbGeAlD
Bosutinib—CLK1—spinal cord—Creutzfeldt-Jakob disease	0.00157	0.00264	CbGeAlD
Bosutinib—TNIK—brain—Creutzfeldt-Jakob disease	0.00157	0.00263	CbGeAlD
Bosutinib—SYK—brain—Creutzfeldt-Jakob disease	0.00157	0.00263	CbGeAlD
Bosutinib—MAP2K5—brainstem—Creutzfeldt-Jakob disease	0.00157	0.00263	CbGeAlD
Bosutinib—EPHA5—central nervous system—Creutzfeldt-Jakob disease	0.00156	0.00262	CbGeAlD
Bosutinib—ALK—central nervous system—Creutzfeldt-Jakob disease	0.00156	0.00262	CbGeAlD
Bosutinib—FER—central nervous system—Creutzfeldt-Jakob disease	0.00156	0.00262	CbGeAlD
Bosutinib—TYRO3—central nervous system—Creutzfeldt-Jakob disease	0.00156	0.00262	CbGeAlD
Bosutinib—ERBB3—lymphoid tissue—Creutzfeldt-Jakob disease	0.00156	0.00262	CbGeAlD
Bosutinib—MAP2K2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00156	0.00261	CbGeAlD
Bosutinib—CDK2—brain—Creutzfeldt-Jakob disease	0.00156	0.00261	CbGeAlD
Bosutinib—LYN—central nervous system—Creutzfeldt-Jakob disease	0.00156	0.0026	CbGeAlD
Bosutinib—MAP3K2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00155	0.00259	CbGeAlD
Bosutinib—BMP2K—spinal cord—Creutzfeldt-Jakob disease	0.00155	0.00259	CbGeAlD
Bosutinib—CAMK2G—spinal cord—Creutzfeldt-Jakob disease	0.00155	0.00259	CbGeAlD
Bosutinib—STK26—brain—Creutzfeldt-Jakob disease	0.00154	0.00259	CbGeAlD
Bosutinib—MAP3K19—central nervous system—Creutzfeldt-Jakob disease	0.00153	0.00256	CbGeAlD
Bosutinib—LRRK2—spinal cord—Creutzfeldt-Jakob disease	0.00153	0.00256	CbGeAlD
Bosutinib—FER—cerebellum—Creutzfeldt-Jakob disease	0.00153	0.00256	CbGeAlD
Bosutinib—EPHA5—cerebellum—Creutzfeldt-Jakob disease	0.00153	0.00256	CbGeAlD
Bosutinib—TYRO3—cerebellum—Creutzfeldt-Jakob disease	0.00153	0.00256	CbGeAlD
Bosutinib—TBK1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00152	0.00254	CbGeAlD
Bosutinib—PTK2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00152	0.00254	CbGeAlD
Bosutinib—TNK2—central nervous system—Creutzfeldt-Jakob disease	0.0015	0.00251	CbGeAlD
Bosutinib—CHEK2—brain—Creutzfeldt-Jakob disease	0.00149	0.0025	CbGeAlD
Bosutinib—WEE1—brain—Creutzfeldt-Jakob disease	0.00148	0.00248	CbGeAlD
Bosutinib—DMPK—brain—Creutzfeldt-Jakob disease	0.00148	0.00248	CbGeAlD
Bosutinib—CSNK1E—spinal cord—Creutzfeldt-Jakob disease	0.00147	0.00246	CbGeAlD
Bosutinib—TNK2—cerebellum—Creutzfeldt-Jakob disease	0.00147	0.00246	CbGeAlD
Bosutinib—ERBB4—central nervous system—Creutzfeldt-Jakob disease	0.00146	0.00245	CbGeAlD
Bosutinib—RPS6KB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00146	0.00244	CbGeAlD
Bosutinib—FGR—lymphoid tissue—Creutzfeldt-Jakob disease	0.00145	0.00243	CbGeAlD
Bosutinib—MAP4K2—cerebellum—Creutzfeldt-Jakob disease	0.00145	0.00242	CbGeAlD
Bosutinib—SIK1—spinal cord—Creutzfeldt-Jakob disease	0.00145	0.00242	CbGeAlD
Bosutinib—IRAK4—spinal cord—Creutzfeldt-Jakob disease	0.00145	0.00242	CbGeAlD
Bosutinib—AXL—lymphoid tissue—Creutzfeldt-Jakob disease	0.00144	0.00242	CbGeAlD
Bosutinib—ROCK1—central nervous system—Creutzfeldt-Jakob disease	0.00144	0.00241	CbGeAlD
Bosutinib—ERBB4—cerebellum—Creutzfeldt-Jakob disease	0.00143	0.00239	CbGeAlD
Bosutinib—STK3—cerebellum—Creutzfeldt-Jakob disease	0.00143	0.00239	CbGeAlD
Bosutinib—ERBB3—spinal cord—Creutzfeldt-Jakob disease	0.00142	0.00237	CbGeAlD
Bosutinib—ULK3—spinal cord—Creutzfeldt-Jakob disease	0.00141	0.00237	CbGeAlD
Bosutinib—MAP2K2—spinal cord—Creutzfeldt-Jakob disease	0.00141	0.00237	CbGeAlD
Bosutinib—STK25—brain—Creutzfeldt-Jakob disease	0.00141	0.00237	CbGeAlD
Bosutinib—EPHA3—brain—Creutzfeldt-Jakob disease	0.0014	0.00235	CbGeAlD
Bosutinib—BMPR2—central nervous system—Creutzfeldt-Jakob disease	0.0014	0.00235	CbGeAlD
Bosutinib—MAP3K7—spinal cord—Creutzfeldt-Jakob disease	0.00139	0.00233	CbGeAlD
Bosutinib—STK36—central nervous system—Creutzfeldt-Jakob disease	0.00139	0.00233	CbGeAlD
Bosutinib—EPHB3—central nervous system—Creutzfeldt-Jakob disease	0.00139	0.00233	CbGeAlD
Bosutinib—TBK1—spinal cord—Creutzfeldt-Jakob disease	0.00137	0.0023	CbGeAlD
Bosutinib—PTK2—spinal cord—Creutzfeldt-Jakob disease	0.00137	0.0023	CbGeAlD
Bosutinib—MERTK—central nervous system—Creutzfeldt-Jakob disease	0.00137	0.0023	CbGeAlD
Bosutinib—PLK2—brain—Creutzfeldt-Jakob disease	0.00137	0.0023	CbGeAlD
Bosutinib—BMPR2—cerebellum—Creutzfeldt-Jakob disease	0.00137	0.00229	CbGeAlD
Bosutinib—SIK3—brain—Creutzfeldt-Jakob disease	0.00136	0.00228	CbGeAlD
Bosutinib—STK36—cerebellum—Creutzfeldt-Jakob disease	0.00136	0.00227	CbGeAlD
Bosutinib—EPHB3—cerebellum—Creutzfeldt-Jakob disease	0.00136	0.00227	CbGeAlD
Bosutinib—EPHA2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00135	0.00227	CbGeAlD
Bosutinib—FYN—lymphoid tissue—Creutzfeldt-Jakob disease	0.00135	0.00226	CbGeAlD
Bosutinib—MAP4K4—central nervous system—Creutzfeldt-Jakob disease	0.00135	0.00226	CbGeAlD
Bosutinib—MERTK—cerebellum—Creutzfeldt-Jakob disease	0.00134	0.00225	CbGeAlD
Bosutinib—BCR—central nervous system—Creutzfeldt-Jakob disease	0.00134	0.00224	CbGeAlD
Bosutinib—MAP3K12—central nervous system—Creutzfeldt-Jakob disease	0.00133	0.00223	CbGeAlD
Bosutinib—RPS6KB1—spinal cord—Creutzfeldt-Jakob disease	0.00132	0.00221	CbGeAlD
Bosutinib—MAP4K5—lymphoid tissue—Creutzfeldt-Jakob disease	0.00132	0.00221	CbGeAlD
Bosutinib—MAP4K4—cerebellum—Creutzfeldt-Jakob disease	0.00132	0.00221	CbGeAlD
Bosutinib—STK4—brain—Creutzfeldt-Jakob disease	0.00131	0.0022	CbGeAlD
Bosutinib—AXL—spinal cord—Creutzfeldt-Jakob disease	0.00131	0.00219	CbGeAlD
Bosutinib—NUAK2—cerebellum—Creutzfeldt-Jakob disease	0.00131	0.00219	CbGeAlD
Bosutinib—BCR—cerebellum—Creutzfeldt-Jakob disease	0.00131	0.00219	CbGeAlD
Bosutinib—STK35—central nervous system—Creutzfeldt-Jakob disease	0.0013	0.00218	CbGeAlD
Bosutinib—MAP2K1—central nervous system—Creutzfeldt-Jakob disease	0.0013	0.00218	CbGeAlD
Bosutinib—MAP3K12—cerebellum—Creutzfeldt-Jakob disease	0.0013	0.00218	CbGeAlD
Bosutinib—CAMK1D—brain—Creutzfeldt-Jakob disease	0.0013	0.00217	CbGeAlD
Bosutinib—CSK—central nervous system—Creutzfeldt-Jakob disease	0.00129	0.00217	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—Creutzfeldt-Jakob disease	0.00129	0.00215	CbGeAlD
Bosutinib—STK24—brain—Creutzfeldt-Jakob disease	0.00128	0.00215	CbGeAlD
Bosutinib—HCK—central nervous system—Creutzfeldt-Jakob disease	0.00128	0.00214	CbGeAlD
Bosutinib—CLK1—central nervous system—Creutzfeldt-Jakob disease	0.00128	0.00214	CbGeAlD
Bosutinib—MAP2K1—cerebellum—Creutzfeldt-Jakob disease	0.00127	0.00213	CbGeAlD
Bosutinib—STK35—cerebellum—Creutzfeldt-Jakob disease	0.00127	0.00213	CbGeAlD
Bosutinib—CSK—cerebellum—Creutzfeldt-Jakob disease	0.00126	0.00212	CbGeAlD
Bosutinib—SLK—spinal cord—Creutzfeldt-Jakob disease	0.00126	0.00211	CbGeAlD
Bosutinib—CSNK1A1—cerebellum—Creutzfeldt-Jakob disease	0.00126	0.0021	CbGeAlD
Bosutinib—CAMK2G—central nervous system—Creutzfeldt-Jakob disease	0.00125	0.0021	CbGeAlD
Bosutinib—BMP2K—central nervous system—Creutzfeldt-Jakob disease	0.00125	0.0021	CbGeAlD
Bosutinib—EPHB4—spinal cord—Creutzfeldt-Jakob disease	0.00125	0.00209	CbGeAlD
Bosutinib—CLK1—cerebellum—Creutzfeldt-Jakob disease	0.00125	0.00209	CbGeAlD
Bosutinib—LRRK2—central nervous system—Creutzfeldt-Jakob disease	0.00124	0.00208	CbGeAlD
Bosutinib—FER—brain—Creutzfeldt-Jakob disease	0.00124	0.00208	CbGeAlD
Bosutinib—EPHA5—brain—Creutzfeldt-Jakob disease	0.00124	0.00208	CbGeAlD
Bosutinib—ALK—brain—Creutzfeldt-Jakob disease	0.00124	0.00208	CbGeAlD
Bosutinib—TYRO3—brain—Creutzfeldt-Jakob disease	0.00124	0.00208	CbGeAlD
Bosutinib—ABL2—cerebellum—Creutzfeldt-Jakob disease	0.00124	0.00208	CbGeAlD
Bosutinib—LYN—brain—Creutzfeldt-Jakob disease	0.00123	0.00207	CbGeAlD
Bosutinib—CAMK2G—cerebellum—Creutzfeldt-Jakob disease	0.00123	0.00205	CbGeAlD
Bosutinib—BMP2K—cerebellum—Creutzfeldt-Jakob disease	0.00123	0.00205	CbGeAlD
Bosutinib—FYN—spinal cord—Creutzfeldt-Jakob disease	0.00122	0.00205	CbGeAlD
Bosutinib—YES1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00122	0.00204	CbGeAlD
Bosutinib—MAP4K1—brain—Creutzfeldt-Jakob disease	0.00122	0.00204	CbGeAlD
Bosutinib—MAP3K19—brain—Creutzfeldt-Jakob disease	0.00122	0.00204	CbGeAlD
Bosutinib—LRRK2—cerebellum—Creutzfeldt-Jakob disease	0.00121	0.00203	CbGeAlD
Bosutinib—ABL1—brainstem—Creutzfeldt-Jakob disease	0.00121	0.00203	CbGeAlD
Bosutinib—EGFR—cerebellum—Creutzfeldt-Jakob disease	0.00121	0.00203	CbGeAlD
Bosutinib—PTK2B—central nervous system—Creutzfeldt-Jakob disease	0.00121	0.00203	CbGeAlD
Bosutinib—BTK—brain—Creutzfeldt-Jakob disease	0.00121	0.00203	CbGeAlD
Bosutinib—STK10—lymphoid tissue—Creutzfeldt-Jakob disease	0.00121	0.00202	CbGeAlD
Bosutinib—TAOK3—lymphoid tissue—Creutzfeldt-Jakob disease	0.0012	0.00202	CbGeAlD
Bosutinib—MAP3K3—spinal cord—Creutzfeldt-Jakob disease	0.0012	0.002	CbGeAlD
Bosutinib—MAP4K5—spinal cord—Creutzfeldt-Jakob disease	0.0012	0.002	CbGeAlD
Bosutinib—TNK2—brain—Creutzfeldt-Jakob disease	0.00119	0.002	CbGeAlD
Bosutinib—CSNK1E—central nervous system—Creutzfeldt-Jakob disease	0.00119	0.00199	CbGeAlD
Bosutinib—PTK2B—cerebellum—Creutzfeldt-Jakob disease	0.00118	0.00198	CbGeAlD
Bosutinib—MAP4K2—brain—Creutzfeldt-Jakob disease	0.00118	0.00197	CbGeAlD
Bosutinib—SRC—lymphoid tissue—Creutzfeldt-Jakob disease	0.00117	0.00196	CbGeAlD
Bosutinib—IRAK4—central nervous system—Creutzfeldt-Jakob disease	0.00117	0.00196	CbGeAlD
Bosutinib—SIK1—central nervous system—Creutzfeldt-Jakob disease	0.00117	0.00196	CbGeAlD
Bosutinib—CSNK1E—cerebellum—Creutzfeldt-Jakob disease	0.00116	0.00195	CbGeAlD
Bosutinib—EPHA4—central nervous system—Creutzfeldt-Jakob disease	0.00116	0.00194	CbGeAlD
Bosutinib—ERBB4—brain—Creutzfeldt-Jakob disease	0.00116	0.00194	CbGeAlD
Bosutinib—STK3—brain—Creutzfeldt-Jakob disease	0.00116	0.00194	CbGeAlD
Bosutinib—ERBB3—central nervous system—Creutzfeldt-Jakob disease	0.00115	0.00192	CbGeAlD
Bosutinib—ULK3—central nervous system—Creutzfeldt-Jakob disease	0.00115	0.00192	CbGeAlD
Bosutinib—MAP2K2—central nervous system—Creutzfeldt-Jakob disease	0.00115	0.00192	CbGeAlD
Bosutinib—SIK1—cerebellum—Creutzfeldt-Jakob disease	0.00115	0.00192	CbGeAlD
Bosutinib—IRAK4—cerebellum—Creutzfeldt-Jakob disease	0.00115	0.00192	CbGeAlD
Bosutinib—ROCK1—brain—Creutzfeldt-Jakob disease	0.00114	0.00192	CbGeAlD
Bosutinib—MAP3K2—central nervous system—Creutzfeldt-Jakob disease	0.00114	0.00191	CbGeAlD
Bosutinib—EPHA4—cerebellum—Creutzfeldt-Jakob disease	0.00113	0.0019	CbGeAlD
Bosutinib—ERBB3—cerebellum—Creutzfeldt-Jakob disease	0.00112	0.00188	CbGeAlD
Bosutinib—MAP2K2—cerebellum—Creutzfeldt-Jakob disease	0.00112	0.00188	CbGeAlD
Bosutinib—ULK3—cerebellum—Creutzfeldt-Jakob disease	0.00112	0.00188	CbGeAlD
Bosutinib—TBK1—central nervous system—Creutzfeldt-Jakob disease	0.00111	0.00187	CbGeAlD
Bosutinib—PTK2—central nervous system—Creutzfeldt-Jakob disease	0.00111	0.00187	CbGeAlD
Bosutinib—MAP3K2—cerebellum—Creutzfeldt-Jakob disease	0.00111	0.00186	CbGeAlD
Bosutinib—BMPR2—brain—Creutzfeldt-Jakob disease	0.00111	0.00186	CbGeAlD
Bosutinib—YES1—spinal cord—Creutzfeldt-Jakob disease	0.00111	0.00185	CbGeAlD
Bosutinib—STK36—brain—Creutzfeldt-Jakob disease	0.0011	0.00185	CbGeAlD
Bosutinib—EPHB3—brain—Creutzfeldt-Jakob disease	0.0011	0.00185	CbGeAlD
Bosutinib—MAP3K7—cerebellum—Creutzfeldt-Jakob disease	0.0011	0.00185	CbGeAlD
Bosutinib—TAOK3—spinal cord—Creutzfeldt-Jakob disease	0.00109	0.00183	CbGeAlD
Bosutinib—MERTK—brain—Creutzfeldt-Jakob disease	0.00109	0.00183	CbGeAlD
Bosutinib—PTK2—cerebellum—Creutzfeldt-Jakob disease	0.00109	0.00182	CbGeAlD
Bosutinib—TBK1—cerebellum—Creutzfeldt-Jakob disease	0.00109	0.00182	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—Creutzfeldt-Jakob disease	0.00107	0.0018	CbGeAlD
Bosutinib—MAP4K4—brain—Creutzfeldt-Jakob disease	0.00107	0.00179	CbGeAlD
Bosutinib—IRAK1—cerebellum—Creutzfeldt-Jakob disease	0.00107	0.00179	CbGeAlD
Bosutinib—FGR—central nervous system—Creutzfeldt-Jakob disease	0.00107	0.00178	CbGeAlD
Bosutinib—SRC—spinal cord—Creutzfeldt-Jakob disease	0.00106	0.00178	CbGeAlD
Bosutinib—NUAK2—brain—Creutzfeldt-Jakob disease	0.00106	0.00178	CbGeAlD
Bosutinib—BCR—brain—Creutzfeldt-Jakob disease	0.00106	0.00178	CbGeAlD
Bosutinib—AXL—central nervous system—Creutzfeldt-Jakob disease	0.00106	0.00178	CbGeAlD
Bosutinib—MAP3K12—brain—Creutzfeldt-Jakob disease	0.00106	0.00177	CbGeAlD
Bosutinib—CSF1R—lymphoid tissue—Creutzfeldt-Jakob disease	0.00105	0.00176	CbGeAlD
Bosutinib—RPS6KB1—cerebellum—Creutzfeldt-Jakob disease	0.00105	0.00175	CbGeAlD
Bosutinib—AXL—cerebellum—Creutzfeldt-Jakob disease	0.00104	0.00174	CbGeAlD
Bosutinib—MAP2K1—brain—Creutzfeldt-Jakob disease	0.00103	0.00173	CbGeAlD
Bosutinib—STK35—brain—Creutzfeldt-Jakob disease	0.00103	0.00173	CbGeAlD
Bosutinib—CSK—brain—Creutzfeldt-Jakob disease	0.00103	0.00172	CbGeAlD
Bosutinib—CSNK1A1—brain—Creutzfeldt-Jakob disease	0.00102	0.00171	CbGeAlD
Bosutinib—CLK1—brain—Creutzfeldt-Jakob disease	0.00101	0.0017	CbGeAlD
Bosutinib—HCK—brain—Creutzfeldt-Jakob disease	0.00101	0.0017	CbGeAlD
Bosutinib—ABL2—brain—Creutzfeldt-Jakob disease	0.00101	0.00169	CbGeAlD
Bosutinib—SLK—cerebellum—Creutzfeldt-Jakob disease	0.000999	0.00167	CbGeAlD
Bosutinib—EPHA2—central nervous system—Creutzfeldt-Jakob disease	0.000995	0.00167	CbGeAlD
Bosutinib—BMP2K—brain—Creutzfeldt-Jakob disease	0.000995	0.00167	CbGeAlD
Bosutinib—CAMK2G—brain—Creutzfeldt-Jakob disease	0.000995	0.00167	CbGeAlD
Bosutinib—FYN—central nervous system—Creutzfeldt-Jakob disease	0.000994	0.00166	CbGeAlD
Bosutinib—EPHB4—cerebellum—Creutzfeldt-Jakob disease	0.000992	0.00166	CbGeAlD
Bosutinib—LRRK2—brain—Creutzfeldt-Jakob disease	0.000986	0.00165	CbGeAlD
Bosutinib—EGFR—brain—Creutzfeldt-Jakob disease	0.000983	0.00165	CbGeAlD
Bosutinib—MAP2K5—spinal cord—Creutzfeldt-Jakob disease	0.000978	0.00164	CbGeAlD
Bosutinib—FYN—cerebellum—Creutzfeldt-Jakob disease	0.000971	0.00163	CbGeAlD
Bosutinib—MAP3K3—central nervous system—Creutzfeldt-Jakob disease	0.000971	0.00163	CbGeAlD
Bosutinib—MAP4K5—central nervous system—Creutzfeldt-Jakob disease	0.000971	0.00163	CbGeAlD
Bosutinib—PTK2B—brain—Creutzfeldt-Jakob disease	0.000961	0.00161	CbGeAlD
Bosutinib—CSF1R—spinal cord—Creutzfeldt-Jakob disease	0.000955	0.0016	CbGeAlD
Bosutinib—MAP4K5—cerebellum—Creutzfeldt-Jakob disease	0.000949	0.00159	CbGeAlD
Bosutinib—MAP3K3—cerebellum—Creutzfeldt-Jakob disease	0.000949	0.00159	CbGeAlD
Bosutinib—CSNK1E—brain—Creutzfeldt-Jakob disease	0.000946	0.00158	CbGeAlD
Bosutinib—CYP3A4—blood plasma—Creutzfeldt-Jakob disease	0.000939	0.00157	CbGeAlD
Bosutinib—PDGFRB—lymphoid tissue—Creutzfeldt-Jakob disease	0.000934	0.00156	CbGeAlD
Bosutinib—SIK1—brain—Creutzfeldt-Jakob disease	0.000931	0.00156	CbGeAlD
Bosutinib—IRAK4—brain—Creutzfeldt-Jakob disease	0.000931	0.00156	CbGeAlD
Bosutinib—EPHA4—brain—Creutzfeldt-Jakob disease	0.000921	0.00154	CbGeAlD
Bosutinib—ERBB3—brain—Creutzfeldt-Jakob disease	0.000912	0.00153	CbGeAlD
Bosutinib—MAP2K2—brain—Creutzfeldt-Jakob disease	0.00091	0.00152	CbGeAlD
Bosutinib—ULK3—brain—Creutzfeldt-Jakob disease	0.00091	0.00152	CbGeAlD
Bosutinib—MAP3K2—brain—Creutzfeldt-Jakob disease	0.000904	0.00151	CbGeAlD
Bosutinib—YES1—central nervous system—Creutzfeldt-Jakob disease	0.000897	0.0015	CbGeAlD
Bosutinib—MAP3K7—brain—Creutzfeldt-Jakob disease	0.000895	0.0015	CbGeAlD
Bosutinib—STK10—central nervous system—Creutzfeldt-Jakob disease	0.000889	0.00149	CbGeAlD
Bosutinib—TAOK3—central nervous system—Creutzfeldt-Jakob disease	0.000885	0.00148	CbGeAlD
Bosutinib—PTK2—brain—Creutzfeldt-Jakob disease	0.000885	0.00148	CbGeAlD
Bosutinib—TBK1—brain—Creutzfeldt-Jakob disease	0.000885	0.00148	CbGeAlD
Bosutinib—YES1—cerebellum—Creutzfeldt-Jakob disease	0.000876	0.00147	CbGeAlD
Bosutinib—STK10—cerebellum—Creutzfeldt-Jakob disease	0.000869	0.00145	CbGeAlD
Bosutinib—IRAK1—brain—Creutzfeldt-Jakob disease	0.000868	0.00145	CbGeAlD
Bosutinib—TAOK3—cerebellum—Creutzfeldt-Jakob disease	0.000865	0.00145	CbGeAlD
Bosutinib—SRC—central nervous system—Creutzfeldt-Jakob disease	0.000863	0.00144	CbGeAlD
Bosutinib—RPS6KB1—brain—Creutzfeldt-Jakob disease	0.000851	0.00143	CbGeAlD
Bosutinib—PDGFRB—spinal cord—Creutzfeldt-Jakob disease	0.000847	0.00142	CbGeAlD
Bosutinib—FGR—brain—Creutzfeldt-Jakob disease	0.000846	0.00142	CbGeAlD
Bosutinib—SRC—cerebellum—Creutzfeldt-Jakob disease	0.000843	0.00141	CbGeAlD
Bosutinib—AXL—brain—Creutzfeldt-Jakob disease	0.000843	0.00141	CbGeAlD
Bosutinib—ABL1—lymphoid tissue—Creutzfeldt-Jakob disease	0.000832	0.00139	CbGeAlD
Bosutinib—SLK—brain—Creutzfeldt-Jakob disease	0.000811	0.00136	CbGeAlD
Bosutinib—EPHB4—brain—Creutzfeldt-Jakob disease	0.000805	0.00135	CbGeAlD
Bosutinib—MAP2K5—central nervous system—Creutzfeldt-Jakob disease	0.000794	0.00133	CbGeAlD
Bosutinib—EPHA2—brain—Creutzfeldt-Jakob disease	0.00079	0.00132	CbGeAlD
Bosutinib—FYN—brain—Creutzfeldt-Jakob disease	0.000789	0.00132	CbGeAlD
Bosutinib—MAP2K5—cerebellum—Creutzfeldt-Jakob disease	0.000776	0.0013	CbGeAlD
Bosutinib—CSF1R—central nervous system—Creutzfeldt-Jakob disease	0.000774	0.0013	CbGeAlD
Bosutinib—MAP3K3—brain—Creutzfeldt-Jakob disease	0.000771	0.00129	CbGeAlD
Bosutinib—MAP4K5—brain—Creutzfeldt-Jakob disease	0.000771	0.00129	CbGeAlD
Bosutinib—CSF1R—cerebellum—Creutzfeldt-Jakob disease	0.000757	0.00127	CbGeAlD
Bosutinib—ABL1—spinal cord—Creutzfeldt-Jakob disease	0.000755	0.00126	CbGeAlD
Bosutinib—YES1—brain—Creutzfeldt-Jakob disease	0.000712	0.00119	CbGeAlD
Bosutinib—STK10—brain—Creutzfeldt-Jakob disease	0.000705	0.00118	CbGeAlD
Bosutinib—TAOK3—brain—Creutzfeldt-Jakob disease	0.000703	0.00118	CbGeAlD
Bosutinib—PDGFRB—central nervous system—Creutzfeldt-Jakob disease	0.000687	0.00115	CbGeAlD
Bosutinib—SRC—brain—Creutzfeldt-Jakob disease	0.000685	0.00115	CbGeAlD
Bosutinib—PDGFRB—cerebellum—Creutzfeldt-Jakob disease	0.000671	0.00112	CbGeAlD
Bosutinib—ABCB1—blood plasma—Creutzfeldt-Jakob disease	0.000665	0.00111	CbGeAlD
Bosutinib—MAP2K5—brain—Creutzfeldt-Jakob disease	0.00063	0.00105	CbGeAlD
Bosutinib—CSF1R—brain—Creutzfeldt-Jakob disease	0.000615	0.00103	CbGeAlD
Bosutinib—ABL1—central nervous system—Creutzfeldt-Jakob disease	0.000612	0.00102	CbGeAlD
Bosutinib—ABL1—cerebellum—Creutzfeldt-Jakob disease	0.000598	0.001	CbGeAlD
Bosutinib—PDGFRB—brain—Creutzfeldt-Jakob disease	0.000545	0.000913	CbGeAlD
Bosutinib—WEE1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000513	0.00127	CbGpPWpGaD
Bosutinib—MAP2K2—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00051	0.00127	CbGpPWpGaD
Bosutinib—TXK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000504	0.00125	CbGpPWpGaD
Bosutinib—PDGFRB—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000498	0.00124	CbGpPWpGaD
Bosutinib—PTK2B—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000492	0.00122	CbGpPWpGaD
Bosutinib—IRAK4—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00049	0.00122	CbGpPWpGaD
Bosutinib—LYN—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000488	0.00121	CbGpPWpGaD
Bosutinib—ABL1—brain—Creutzfeldt-Jakob disease	0.000486	0.000814	CbGeAlD
Bosutinib—ABL1—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000485	0.00121	CbGpPWpGaD
Bosutinib—FYN—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00048	0.00119	CbGpPWpGaD
Bosutinib—MAP2K1—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000478	0.00119	CbGpPWpGaD
Bosutinib—EGFR—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.000477	0.00118	CbGpPWpGaD
Bosutinib—HCK—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000471	0.00117	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.000464	0.00115	CbGpPWpGaD
Bosutinib—MAP2K2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000457	0.00114	CbGpPWpGaD
Bosutinib—LCK—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.000449	0.00112	CbGpPWpGaD
Bosutinib—PTK2B—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000437	0.00108	CbGpPWpGaD
Bosutinib—LYN—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000437	0.00108	CbGpPWpGaD
Bosutinib—BTK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000437	0.00108	CbGpPWpGaD
Bosutinib—ABL1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000435	0.00108	CbGpPWpGaD
Bosutinib—FYN—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00043	0.00107	CbGpPWpGaD
Bosutinib—MAP2K1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000428	0.00106	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000424	0.00105	CbGpPWpGaD
Bosutinib—SRMS—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000422	0.00105	CbGpPWpGaD
Bosutinib—PTK2—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.00042	0.00104	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000418	0.00104	CbGpPWpGaD
Bosutinib—SRC—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.000407	0.00101	CbGpPWpGaD
Bosutinib—SYK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000403	0.001	CbGpPWpGaD
Bosutinib—LCK—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.0004	0.000992	CbGpPWpGaD
Bosutinib—PRKCQ—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000395	0.000982	CbGpPWpGaD
Bosutinib—SYK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000392	0.000974	CbGpPWpGaD
Bosutinib—YES1—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000386	0.000959	CbGpPWpGaD
Bosutinib—PRKCQ—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000385	0.000956	CbGpPWpGaD
Bosutinib—IKBKE—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000382	0.000949	CbGpPWpGaD
Bosutinib—CSK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000382	0.000948	CbGpPWpGaD
Bosutinib—ERBB4—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000377	0.000937	CbGpPWpGaD
Bosutinib—SRMS—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000375	0.000931	CbGpPWpGaD
Bosutinib—CSK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000372	0.000923	CbGpPWpGaD
Bosutinib—EGFR—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000372	0.000923	CbGpPWpGaD
Bosutinib—IRAK1—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000366	0.00091	CbGpPWpGaD
Bosutinib—BLK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000363	0.000901	CbGpPWpGaD
Bosutinib—TXK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000359	0.000892	CbGpPWpGaD
Bosutinib—SRC—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000354	0.000879	CbGpPWpGaD
Bosutinib—SYK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000348	0.000865	CbGpPWpGaD
Bosutinib—MAP3K7—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000345	0.000857	CbGpPWpGaD
Bosutinib—YES1—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000343	0.000852	CbGpPWpGaD
Bosutinib—PRKCQ—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000342	0.000849	CbGpPWpGaD
Bosutinib—ABCB1—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.00034	0.000845	CbGpPWpGaD
Bosutinib—CDK2—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000336	0.000835	CbGpPWpGaD
Bosutinib—SYK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000334	0.000829	CbGpPWpGaD
Bosutinib—ERBB3—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000333	0.000826	CbGpPWpGaD
Bosutinib—CSK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00033	0.00082	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000328	0.000814	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000326	0.00081	CbGpPWpGaD
Bosutinib—IRAK1—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000325	0.000808	CbGpPWpGaD
Bosutinib—PHKG1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000322	0.000799	CbGpPWpGaD
Bosutinib—TXK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000319	0.000792	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000317	0.000787	CbGpPWpGaD
Bosutinib—CSK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000317	0.000786	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000312	0.000774	CbGpPWpGaD
Bosutinib—BTK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000311	0.000772	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00031	0.00077	CbGpPWpGaD
Bosutinib—LYN—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000309	0.000768	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000307	0.000762	CbGpPWpGaD
Bosutinib—MAP3K7—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000306	0.000761	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000305	0.000758	CbGpPWpGaD
Bosutinib—FYN—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000304	0.000756	CbGpPWpGaD
Bosutinib—MAP2K2—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000302	0.000749	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000297	0.000739	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000292	0.000725	CbGpPWpGaD
Bosutinib—LYN—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000288	0.000715	CbGpPWpGaD
Bosutinib—TBK1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000284	0.000705	CbGpPWpGaD
Bosutinib—FYN—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000284	0.000704	CbGpPWpGaD
Bosutinib—MAP2K1—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000282	0.0007	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000279	0.000692	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.000277	0.000689	CbGpPWpGaD
Bosutinib—BTK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000276	0.000686	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000272	0.000676	CbGpPWpGaD
Bosutinib—IKBKE—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000272	0.000676	CbGpPWpGaD
Bosutinib—CYP3A4—central nervous system—Creutzfeldt-Jakob disease	0.000269	0.00045	CbGeAlD
Bosutinib—ERBB4—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000269	0.000668	CbGpPWpGaD
Bosutinib—MAP2K2—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000268	0.000665	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000265	0.000658	CbGpPWpGaD
Bosutinib—BTK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000265	0.000657	CbGpPWpGaD
Bosutinib—FGR—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000265	0.000657	CbGpPWpGaD
Bosutinib—BCR—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000262	0.000652	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000261	0.000647	CbGpPWpGaD
Bosutinib—ABCB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.000259	0.000433	CbGeAlD
Bosutinib—BLK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000259	0.000642	CbGpPWpGaD
Bosutinib—LYN—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000256	0.000635	CbGpPWpGaD
Bosutinib—LCK—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000253	0.000629	CbGpPWpGaD
Bosutinib—SRC—Membrane Trafficking—YWHAZ—Creutzfeldt-Jakob disease	0.000253	0.000629	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000253	0.000628	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000253	0.000628	CbGpPWpGaD
Bosutinib—FYN—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000252	0.000625	CbGpPWpGaD
Bosutinib—MAP2K1—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00025	0.000622	CbGpPWpGaD
Bosutinib—HCK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000243	0.000603	CbGpPWpGaD
Bosutinib—IKBKE—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000242	0.0006	CbGpPWpGaD
Bosutinib—ERBB4—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000239	0.000593	CbGpPWpGaD
Bosutinib—SYK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000238	0.000591	CbGpPWpGaD
Bosutinib—ERBB3—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000237	0.000589	CbGpPWpGaD
Bosutinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000236	0.000586	CbGpPWpGaD
Bosutinib—ABCB1—spinal cord—Creutzfeldt-Jakob disease	0.000235	0.000393	CbGeAlD
Bosutinib—PRKCQ—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000234	0.00058	CbGpPWpGaD
Bosutinib—BLK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00023	0.00057	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000229	0.000568	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000226	0.000562	CbGpPWpGaD
Bosutinib—CSK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000226	0.00056	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000226	0.00056	CbGpPWpGaD
Bosutinib—SRC—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000224	0.000557	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000222	0.000552	CbGpPWpGaD
Bosutinib—BLK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00022	0.000547	CbGpPWpGaD
Bosutinib—FGR—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000219	0.000545	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000218	0.000541	CbGpPWpGaD
Bosutinib—PTK2—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000217	0.000538	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000214	0.000532	CbGpPWpGaD
Bosutinib—YES1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000214	0.000531	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000212	0.000526	CbGpPWpGaD
Bosutinib—SYK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000211	0.000525	CbGpPWpGaD
Bosutinib—ERBB3—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00021	0.000523	CbGpPWpGaD
Bosutinib—LCK—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00021	0.000521	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000208	0.000517	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000207	0.000515	CbGpPWpGaD
Bosutinib—TBK1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000202	0.000502	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000202	0.000501	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000201	0.000499	CbGpPWpGaD
Bosutinib—CSK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.0002	0.000497	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000199	0.000493	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000194	0.000482	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000192	0.000476	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000191	0.000475	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000191	0.000475	CbGpPWpGaD
Bosutinib—ABCB1—central nervous system—Creutzfeldt-Jakob disease	0.00019	0.000319	CbGeAlD
Bosutinib—BTK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000189	0.000468	CbGpPWpGaD
Bosutinib—ABCB1—cerebellum—Creutzfeldt-Jakob disease	0.000186	0.000312	CbGeAlD
Bosutinib—MAP3K7—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000186	0.000461	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000185	0.00046	CbGpPWpGaD
Bosutinib—CSK—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000185	0.000459	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000185	0.000459	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000184	0.000456	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00018	0.000448	CbGpPWpGaD
Bosutinib—TBK1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00018	0.000446	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00018	0.000446	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000178	0.000443	CbGpPWpGaD
Bosutinib—YES1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000177	0.00044	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000176	0.000438	CbGpPWpGaD
Bosutinib—HCK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000173	0.00043	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000172	0.000428	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000168	0.000417	CbGpPWpGaD
Bosutinib—BTK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000168	0.000416	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000165	0.00041	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000163	0.000405	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000161	0.000399	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000161	0.000399	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00016	0.000398	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000159	0.000396	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000159	0.000394	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000158	0.000393	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000158	0.000393	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000158	0.000392	CbGpPWpGaD
Bosutinib—BLK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000157	0.000389	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000157	0.000389	CbGpPWpGaD
Bosutinib—FGR—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000156	0.000388	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000155	0.000385	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000155	0.000384	CbGpPWpGaD
Bosutinib—HCK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000154	0.000382	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000153	0.000379	CbGpPWpGaD
Bosutinib—ABCB1—brain—Creutzfeldt-Jakob disease	0.000151	0.000253	CbGeAlD
Bosutinib—ERBB4—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000145	0.00036	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000144	0.000357	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000143	0.000354	CbGpPWpGaD
Bosutinib—HCK—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000142	0.000352	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000141	0.000349	CbGpPWpGaD
Bosutinib—BLK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000139	0.000346	CbGpPWpGaD
Bosutinib—FGR—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000139	0.000345	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000138	0.000343	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000138	0.000342	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000137	0.000339	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000136	0.000337	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000135	0.000335	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000134	0.000333	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000134	0.000333	CbGpPWpGaD
Bosutinib—ERBB4—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000134	0.000332	CbGpPWpGaD
Bosutinib—LYN—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000132	0.000328	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000132	0.000328	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000132	0.000327	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000131	0.000326	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000131	0.000324	CbGpPWpGaD
Bosutinib—FYN—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00013	0.000323	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000129	0.000321	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000129	0.000321	CbGpPWpGaD
Bosutinib—PTK2—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000128	0.000318	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000128	0.000317	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000127	0.000316	CbGpPWpGaD
Bosutinib—YES1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000126	0.000313	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00012	0.000297	CbGpPWpGaD
Bosutinib—ERBB3—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000118	0.000293	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000117	0.000291	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000116	0.000287	CbGpPWpGaD
Bosutinib—PTK2—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000114	0.000282	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000113	0.00028	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000113	0.00028	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000113	0.00028	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000112	0.000279	CbGpPWpGaD
Bosutinib—YES1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000112	0.000278	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000108	0.000269	CbGpPWpGaD
Bosutinib—LCK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000108	0.000269	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000106	0.000264	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.0001	0.000248	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.0001	0.000248	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	9.85e-05	0.000245	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	9.61e-05	0.000239	CbGpPWpGaD
Bosutinib—SRC—Immune System—CTSD—Creutzfeldt-Jakob disease	9.58e-05	0.000238	CbGpPWpGaD
Bosutinib—LYN—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	9.41e-05	0.000234	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	9.37e-05	0.000233	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	9.36e-05	0.000232	CbGpPWpGaD
Bosutinib—FYN—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	9.26e-05	0.00023	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	9.23e-05	0.000229	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	9.21e-05	0.000229	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.89e-05	0.000221	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—YWHAZ—Creutzfeldt-Jakob disease	8.74e-05	0.000217	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.56e-05	0.000213	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.56e-05	0.000213	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—YWHAZ—Creutzfeldt-Jakob disease	8.53e-05	0.000212	CbGpPWpGaD
Bosutinib—LYN—Immune System—YWHAZ—Creutzfeldt-Jakob disease	8.35e-05	0.000207	CbGpPWpGaD
Bosutinib—ABL1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	8.32e-05	0.000206	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.25e-05	0.000205	CbGpPWpGaD
Bosutinib—FYN—Immune System—YWHAZ—Creutzfeldt-Jakob disease	8.23e-05	0.000204	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	8.18e-05	0.000203	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	8.1e-05	0.000201	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—YWHAZ—Creutzfeldt-Jakob disease	8.07e-05	0.0002	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	8e-05	0.000199	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—YWHAZ—Creutzfeldt-Jakob disease	7.88e-05	0.000196	CbGpPWpGaD
Bosutinib—LCK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	7.71e-05	0.000192	CbGpPWpGaD
Bosutinib—FYN—Disease—YWHAZ—Creutzfeldt-Jakob disease	7.59e-05	0.000189	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—YWHAZ—Creutzfeldt-Jakob disease	7.55e-05	0.000188	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	7.35e-05	0.000182	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	7.27e-05	0.000181	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	7.24e-05	0.00018	CbGpPWpGaD
Bosutinib—EGFR—Immune System—YWHAZ—Creutzfeldt-Jakob disease	7.11e-05	0.000176	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	6.87e-05	0.000171	CbGpPWpGaD
Bosutinib—LCK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	6.85e-05	0.00017	CbGpPWpGaD
Bosutinib—SRC—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	6.83e-05	0.00017	CbGpPWpGaD
Bosutinib—EGFR—Disease—YWHAZ—Creutzfeldt-Jakob disease	6.56e-05	0.000163	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	6.47e-05	0.000161	CbGpPWpGaD
Bosutinib—LCK—Disease—YWHAZ—Creutzfeldt-Jakob disease	6.32e-05	0.000157	CbGpPWpGaD
Bosutinib—SRC—Immune System—YWHAZ—Creutzfeldt-Jakob disease	6.06e-05	0.000151	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	5.65e-05	0.00014	CbGpPWpGaD
Bosutinib—SRC—Disease—YWHAZ—Creutzfeldt-Jakob disease	5.6e-05	0.000139	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	5.52e-05	0.000137	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	5.4e-05	0.000134	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	5.32e-05	0.000132	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	5.29e-05	0.000131	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	4.59e-05	0.000114	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	4.48e-05	0.000111	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	4.43e-05	0.00011	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	3.92e-05	9.73e-05	CbGpPWpGaD
